2022
Renal tubular acidosis and associated factors in patients with primary Sjögren’s syndrome: a registry-based study
Zhang Y, Qiao L, Zhang L, Li Q, Yang P, Kong X, Duan X, Zhang M, Li X, Wang Y, Xu J, Wang Y, Hsieh E, Zhao J, Xu D, Li M, Zhao Y, Zeng X. Renal tubular acidosis and associated factors in patients with primary Sjögren’s syndrome: a registry-based study. Clinical Rheumatology 2022, 42: 431-441. PMID: 36383239, DOI: 10.1007/s10067-022-06426-2.Peer-Reviewed Original ResearchConceptsRenal tubular acidosisPrimary Sjögren's syndromePSS patientsEarly disease onsetDisease onsetRenal involvementSjögren's syndromeKidney functionTubular acidosisEULAR Sjögren's Syndrome Disease Activity IndexSjögren's Syndrome Disease Activity IndexMethodThis case-control studyElevated alkaline phosphatase levelsSubjective dry mouthDisease activity indexHigh disease activityGlomerular filtration rateRegistry-based studyErythrocyte sedimentation rateYoung female patientCase-control studyLogistic regression analysisAlkaline phosphatase levelsAntibody positivityDisease activityPrevalence, Predictors, and Prognostic Benefits of Remission Achievement in Patients With Systemic Lupus Erythematosus: A Systematic Review
Yang Z, Cheng C, Wang Z, Wang Y, Zhao J, Wang Q, Tian X, Hsieh E, Li M, Zeng X. Prevalence, Predictors, and Prognostic Benefits of Remission Achievement in Patients With Systemic Lupus Erythematosus: A Systematic Review. Arthritis Care & Research 2022, 74: 208-218. PMID: 32986933, DOI: 10.1002/acr.24464.Peer-Reviewed Original ResearchConceptsSystemic lupus erythematosusPrognostic benefitDisease activityRemission achievementLupus erythematosusRemission statusLower baseline disease activityMajor organ involvementBaseline disease activityClinical disease activityRisk stratification modelPositive serologic resultsDefinition of remissionSLE patientsAdult patientsOrgan involvementDrug withdrawalTreatment adjustmentEmbase databasesRemission definitionsRemissionSerologic activitySerologic resultsPatientsSystematic review
2020
Chinese registry of rheumatoid arthritis (CREDIT): III. The transition of disease activity during follow‐ups and predictors of achieving treatment target
Xiang Y, Wang Q, Li H, Duan X, Fang Y, Yang P, Li Q, Wu R, Huo Y, Shi X, Wu Z, Wang Y, Jiang N, Hsieh E, Li M, Tian X, Zeng X, co‐authors C. Chinese registry of rheumatoid arthritis (CREDIT): III. The transition of disease activity during follow‐ups and predictors of achieving treatment target. International Journal Of Rheumatic Diseases 2020, 23: 1719-1727. PMID: 33034424, DOI: 10.1111/1756-185x.13996.Peer-Reviewed Original ResearchConceptsBiologic disease-modifying anti-rheumatic drugsDisease activityTreatment responseChinese RegistryRheumatoid arthritisDisease-modifying anti-rheumatic drugsBaseline Disease Activity ScoreConventional DMARD therapyLower baseline DAS28Baseline disease activityDisease Activity ScoreAnti-rheumatic drugsBaseline DAS28DMARD therapyLDA ratesPrednisolone usageSynthetic DMARDsEarly RADisease durationActivity scoreTreatment strategiesTreatment targetsYounger agePatientsBaseline
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply